. Oxidant-increased endothelial permeability: prevention with phosphodiesterase inhibition vs. cAMP production. J. Appl. Physiol. 88: 835-842, 2000.-The present objective was to determine whether hydrogen peroxide (H 2 O 2 ) increases transvascular albumin clearance and lung weight in an isolated rat lung and whether posttreatment with cAMP-enhancing agents can prevent these increases. Transvascular albumin clearance was assessed by 125 I-labeled albumin clearance ( 125 I-albumin flux/perfusate concentration of 125 I-albumin) at a given fluid filtration. Nonlinear regression analysis of transvascular albumin clearance vs. fluid filtration yielded values for the permeabilitysurface area product (PS) and the reflection coefficient (). H 2 O 2 decreased from a control value of 0.93 to 0.38, did not change PS, and increased lung weight. Posttreatment with isoproterenol, a ␤ 2 -adrenergic-receptor agonist, reduced the H 2 O 2 -induced decrease in to 0.65 and augmented the increase in lung weight. Posttreatment with CP-80633, a phosphodiesterase 4 inhibitor, further reduced the H 2 O 2 -induced decrease in to 0.79 and blocked the rise in lung weight. In the presence of isoproterenol or CP-80633, H 2 O 2 increased PS. Therefore, H 2 O 2 increased the convective and diffusive clearances of albumin across an intact pulmonary vasculature. Furthermore, inhibition of cAMP metabolism more effectively attenuated the H 2 O 2 -induced increases in convective albumin clearance and lung weight as compared with stimulation of cAMP production.
isoproterenol; phosphodiesterase inhibitor; desferrioxamine; iron chelator; permeability-surface area product; reflection coefficient; vascular pressure; vascular resistance; lung weight POLYMORPHONUCLEAR LEUKOCYTES become primed by inflammatory agents released at sites of injury or circulating in the vasculature (4, 22, 33) . On attachment to vascular endothelial cells and/or after emigration into the underlying tissue, polymorphonuclear leukocytes become activated, resulting in the release of highly toxic reactive oxygen species such as hydrogen peroxide (H 2 O 2 ) and cytoplasmic granules (6) . H 2 O 2 generated extracellularly can freely enter the endothelial cell where it has been shown to target and affect various cellular components (6, 11, 24, 25) . These cellular changes ultimately result in an increase in the passage of protein and water across the vascular endothelium, leading to edema, abnormalities in gas exchange, and finally pulmonary insufficiency or the acute respiratory distress syndrome (3) . We have shown that an infusion of H 2 O 2 can increase the transvascular clearance of 125 I-labeled albumin in an isolated, perfused rabbit lung under isogravimetric conditions (31) . However, the effect of H 2 O 2 , or any other oxidant, on transvascular protein clearance under nonisogravimetric conditions, where both the diffusive and convective clearances of protein can be affected, has not been evaluated in an intact vasculature.
Previous studies have demonstrated the permeabilitydecreasing activity of cAMP-enhancing agents using a variety of inflammatory agents, diseases, and syndromes (1, 7, 15, 18-21, 26, 28, 29) . However, the ability of cAMP-enhancing agents to prevent a H 2 O 2 or any oxidant-induced increase in transvascular protein clearance in an intact vasculature has not been evaluated. Previous studies in the isolated lung have relied on the measurements of the capillary filtration coefficient (K f ) and lung weight to assess the efficacy of cAMPenhancing agents (7, 26) . These two parameters, however, are profoundly affected by changes in vascular surface area; therefore, it is difficult to make definitive conclusions about changes in endothelial barrier function induced by vasoactive agents such as H 2 O 2 and cAMP-enhancing agents by using measurements of K f and lung weight.
Drug therapy to increase intracellular levels of cAMP can take on many forms, such as stimulation of the ␤ 2 -adrenergic receptor by isoproterenol, stimulation of adenylate cyclase by forskolin, the use of a cellpermeable analog such as 8-bromo-cAMP, or inhibition of phosphodiesterases that metabolize cAMP to 5Ј-AMP. Recent developments in the literature would suggest that H 2 O 2 and/or its metabolite, the hydroxyl radical (⅐ OH), may adversely affect ␤ 2 -adrenergic receptors (5) . Thus the use of agonists that stimulate ␤ 2 -adrenergic receptors may not be as effective as compared with, for example, drugs that inhibit cAMP metabolism in preventing an oxidant-induced increase in transvascular protein clearance.
The first objective of the present study was to determine whether H 2 O 2 increases the diffusive and convective clearances of albumin across an intact vasculature under nonisogravimetric conditions. The second objec-
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tive was to determine the efficacy of posttreatment with cAMP-enhancing agents that function to either stimulate production or inhibit metabolism of cAMP on prevention of the increased transvascular albumin clearance induced by H 2 O 2 . The isolated, perfused rat lung was utilized because it represents an intact vascular endothelium. Furthermore, it allows for the measurement of 125 I-albumin clearance and the subsequent calculation of the permeability-surface area product (PS), as a measure of diffusive albumin permeability, and of the reflection coefficient (), a measure of convective albumin clearance. The measurement of is independent of changes in vascular surface area and, unlike the measurements of PS, K f , and lung weight, is not affected by the vasoactive properties of H 2 O 2 and cAMP-enhancing agents.
METHODS
Isolated, perfused rat lung preparation. Protocols for animal care and experimental design were approved by the Institutional Animal Care and Use Committee at Albany Medical College. Male Sprague-Dawley rats (250-350 g) were injected intraperitoneally with pentobarbital sodium (0.65 mg/kg) and administered heparin (1,000 U/kg) via the penile vein before surgery. Lungs were isolated as described previously (15, 30, 34) . Briefly, lungs and heart were suspended from a beam balance, and the pulmonary artery and left atrium were cannulated and perfused with a Ringer phosphate solution containing 2% (wt/vol) BSA. The perfusate (125 ml) was recirculated at 28 ml/min (ϳ50% of the normal cardiac output of a rat), maintained at 38°C and a pH of 7.4, and continuously oxygenated. Lungs were maintained in zone 3 of West with a venous pressure of 4 cmH 2 O and an alveolar pressure of 2 cmH 2 O. Lung weight was measured by a sensitive displacement transducer attached to a beam balance. A change of 200 mg was equal to a 1-cm deflection. Wet weight of the lungs was normalized to dry weight to allow for comparison of lung weights among rats. Pulmonary arterial and left atrial pressures and weight were continuously recorded on a multichannel strip-chart recorder (model 7D polygraph, Grass Instruments). Pulmonary arterial and left atrial cannulas had in-line solenoids, allowing for rapid simultaneous occlusion to determine capillary pressure. Pulmonary vascular resistances were determined from the differences between the capillary pressure and the arterial pressure or venous pressure divided by the flow rate.
Measurement of 125 I-albumin clearance. Albumin clearance (J s /C p , where J s is transvascular 125 I-albumin flux and C p is the perfusate concentration of 125 I-albumin) was determined at t ϭ 60 min after a 3-min exposure of the lungs to 125 I-albumin at different rates of fluid filtration (J v ) by using the method of Kern et al. (13) . Albumin clearance was calculated by using the equation
where A is the amount of 125 I-albumin in the tissue in counts per minute per gram dry lung, t is the exposure time in minutes, and C p is in counts per minute per milliliter. Albumin clearance was used to calculate PS and for albumin, as previously described (15, 30, 34) , by using the nonlinear flux equation of Patlack et al. (23) 
For control and experimental rats, albumin clearance was measured either under isogravimetric conditions or during a weight gain (increased J v ) induced by transiently raising the venous outflow cannula and thus venous pressure. The J v following the increase in venous pressure was calculated from the slow component of the weight-gain curve, as determined in the calculation of K f . Values for PS and were calculated from a nonlinear regression analysis of J s /C p vs. J v by using Eq. 3 (Statistica). In some experiments, PS was determined from tissue counts or J s /C p obtained at a J v of 0.
125 I-albumin was prepared with Na-125 I and BSA by using the chloramine-T procedure as described previously (2) . BSA was passed over a Blue Sepharose affinity column to remove IgG contamination. To ensure that monomeric albumin was used in these experiments, albumin was passed over a Sephacryl 200 column, and the purity was checked by using SDS-PAGE. After iodination, the 125 I-albumin was separated from free 125 I by dialysis (Spectrapore; 14,000 mol wt cutoff, Spectrum) against normal saline (0.9%) and was maintained under dialysis until the day of the experiment. The 125 I-albumin was used only in experiments if the percent free was Ͻ0.1% as determined by comparing isotope stock to filtrate from ultrafiltration cones (CF30; 30,000 mol wt cutoff, Amicon).
Experimental protocols for H 2 O 2 . These studies consisted of two protocols: 1) the effect of iron on the H 2 O 2 -induced increase in lung weight and 2) the effect of an infusion of H 2 O 2 on transvascular clearance of 125 I-albumin and the calculated parameters, PS and .
Desferrioxamine (DFO) chelation of free iron in albumin perfusate. The artificial perfusate used in this isolated lung model was found to contain ϳ90 µM iron (Sigma Chemical quality control sheet), which could convert extracellularly the infused H 2 O 2 to the ⅐ OH via the Fenton reaction (8, 16) . Because an objective of these studies was to assess the effect of H 2 O 2 on transvascular albumin clearance, it was important to maximize the delivery of H 2 O 2 to the pulmonary endothelial cells. To achieve this end, DFO, an iron chelator, was used to bind extracellular iron in the perfusate. Two types of DFO were used, low molecular weight (i.e., 400) DFO, which is reported to be cell permeable (16) , and DFO conjugated to hydroxyethyl starch (HES-DFO; 40,000-70,000 mol wt), which is impermeable to cells and thus binds only extracellular iron. The ability of DFO to lower the concentration of iron in the perfusate was analyzed by inductively coupled plasma emission spectroscopy (ICP 2.5, Leeman Labs). Nontreated and DFO-treated perfusates (5-ml samples) were dialyzed against 0.9% saline (2 liters; 3ϫ) to remove DFO and DFO-iron from the samples. Aliquots (1 ml) of the samples were dried at 60°C for 8 h and ashed at 450°C for 12 h. The ashed samples were reconstituted in 1.5 ml of 10% HNO 3 , weighed, and brought to a near boil for 20 min. Samples were cooled and brought back to their original weight with distilled water. An additional 1.5 ml of distilled water were added before analysis of the iron concentration. The effect of DFO on the H 2 O 2 -induced gain in lung weight was assessed by infusing H 2 O 2 at 40 nmol · ml Ϫ1 · min Ϫ1 into the pulmonary arterial line of the isolated rat lung perfused without or with 150 µM DFO or HES-DFO. The experiments were run as a time course study and concluded when lung weight increased by ϳ1.5 g, which was a doubling of the wet lung weight.
H 2 O 2 infusion and measurements of pulmonary hemodynamics, lung weight, and transvascular albumin clearance.
The effect of H 2 O 2 on transvascular albumin clearance was assessed in the presence of 150 µM HES-DFO. The rate of infusion of H 2 O 2 was 80 nmol·ml Ϫ1 ·min Ϫ1 for 15 min, followed by 60 nmol·ml Ϫ1 ·min Ϫ1 for 10 min, 40 nmol·ml Ϫ1 ·min Ϫ1 for 15 min, and 20 nmol · ml Ϫ1 ·min Ϫ1 for 10 min (see Fig. 2 ). Control lungs were infused with Ringer phosphate solution at the same infusion rate. The measurement of 125 I-albumin clearance was performed at 60 min. To demonstrate that the infused H 2 O 2 was taken up continuously by the lungs and did not increase in concentration in the perfusate, the concentration of H 2 O 2 in the perfusate entering and exiting the lungs was determined by the xylenol orange assay (12) . Samples (900 µl) of perfusate were incubated at 27°C for 45 min with 100 µl of a 10ϫ xylenol orange stock solution [ Experimental protocol for cAMP-enhancing agents. On the day of the experiment, 25 mg of isoproterenol (Sigma Chemical) were dissolved in 10 ml of perfusate, resulting in a 10 mM stock solution. Thirty minutes after the start of the H 2 O 2 infusion, 100 µl of the isoproterenol stock solution were injected into the 125-ml recirculating reservoir, resulting in a final concentration of 8 µM. CP-80633 (5 mg), a gift from Pfizer, was dissolved in 2 ml of 100% DMSO so that its stock concentration was 15 mM. Samples were aliquoted and stored at 4°C until needed. Thirty minutes after the start of the H 2 O 2 infusion, 10 µl of the CP-80633 stock were diluted with 490 µl of perfusate (300 µM CP-80633), of which 400 µl were injected into the 125-ml recirculating reservoir, resulting in a final concentration of 1 µM (Ͻ0.1% DMSO). The drug vehicle, either perfusate or perfusate with DMSO (0.1%), was administered in control studies.
Statistics. Lung weight and hemodynamics were analyzed by using a two-way ANOVA with repeated measures. A Newman-Keuls multiple-range test was used to evaluate significant differences between groups and times (32) . Nonlinear regression analysis was performed on the 125 I-albumin clearance data as a function of J v to calculate PS and . Student's t-tests with Bonferroni correction for multiple comparisons were performed to determine differences in PS and between groups (32). Statistical significance was set at P Ͻ 0.05.
RESULTS

DFO chelation of free iron in albumin perfusate.
While developing a protocol to measure the levels of H 2 O 2 in the recirculating perfusate of the isolated rat lung, we observed that the H 2 O 2 concentration decreased rapidly in perfusate that contained albumin as opposed to perfusate without albumin. Perfusate with albumin contained 73.3 Ϯ 0.2 µM free iron as measured by inductively coupled plasma emission spectroscopy.
To minimize the content of free iron in the perfusate and the potential extracellular conversion of H 2 O 2 to an iron-dependent metabolite such as ⅐ OH, DFO (150 µM) was added to the perfusate and was found to significantly reduce the free iron to 8.0 Ϯ 0.3 µM (Table 1) . It has been reported that DFO is cell permeable and can affect the intracellular conversion of H 2 O 2 to ⅐ OH (16) . Therefore, DFO coupled to HES (HES-DFO, 150 µM) was also used.
The effectiveness of DFO and HES-DFO in delaying the onset of increased lung weight induced by H 2 O 2 was assessed as depicted in Fig. 1 . H 2 O 2 was infused at a rate of 40 nmol · ml Ϫ1· min Ϫ1 into the pulmonary arterial line. Without DFO in the perfusate, lung weight remained fairly constant for 30 min and then rapidly increased by 40 min, resulting in fulminant alveolar edema. With DFO or HES-DFO in the perfusate, lung weight increased steadily for 80 min until alveolar Values are means Ϯ SE; n ϭ 3 samples analyzed. Content of iron was analyzed by inductively coupled plasma emission spectroscopy. * DFO-treated perfusate vs. nontreated perfusate, P Ͻ 0.05. edema developed by 90 min. Because HES-DFO was able to delay the onset of fulminant alveolar edema, presumably by chelating free extracellular iron, we incorporated it into all of the studies to maximize the delivery of H 2 O 2 to the endothelial cells.
H 2 O 2 infusion and measurements of pulmonary hemodynamics, lung weight, and transvascular albumin clearance. H 2 O 2 was infused at a rate of 80 nmole · ml Ϫ1 · min Ϫ1 for 15 min, 60 nmol · ml Ϫ1 · min Ϫ1 for 10 min, 40 nmol · ml Ϫ1 · min Ϫ1 for 15 min, and 20 nmol · ml Ϫ1 · min Ϫ1 for 10 min into the pulmonary arterial line. This infusion scheme was chosen because it did not produce fulminate alveolar edema but did significantly increase pulmonary arterial and capillary pressures (Table 2) , pulmonary arterial and venous resistances (Table 2) , lung weight (Fig. 2) , and the transvascular clearance of 125 I-albumin at 60 min (Table  3 and Fig. 3 ). Nonlinear regression fit of the data representing 125 I-albumin clearance (J s /C p ) as a function of J v allowed for the calculation of PS (denoted by the y-intercept) and (denoted by the slope of the line, 1 Ϫ ). Nonlinear regression analysis revealed that H 2 O 2 decreased from a control value of 0.93 Ϯ 0.02 to 0.38 Ϯ 0.05. H 2 O 2 alone did not change PS from control values ( Fig. 3 and Table 3 ). These findings demonstrate that H 2 O 2 can increase the convective clearance of albumin across the intact vasculature of the isolated, perfused rat lung.
Posttreatment with isoproterenol. To determine the effects of stimulation of cAMP production on the H 2 O 2 -induced increases in hemodynamics, weight, and albumin clearance of the lung, 8 µM isoproterenol was injected as a bolus into the recirculating reservoir 30 min into the infusion of H 2 O 2 . The H 2 O 2 -induced increases in pulmonary arterial pressure and pulmonary arterial resistance were reduced within 10 min by isoproterenol (Table 2) in association with a further increase in lung weight, presumably due to an increase in vascular surface area (Fig. 2 ). Isoproterenol partially reduced the H 2 O 2 -induced decrease in from 0.38 Ϯ Values are means Ϯ SE; n, no. of rats in each group is the same as in Fig. 2 . Arterial pressure was recorded online, capillary pressure was determined by double-occlusion technique, and resistances were determined from pre-and postcapillary pressure differences divided by flow rate of perfusate (28 ml/min). Start of H 2 O 2 infusion was at time 0; addition of cAMP-enhancing agents was at 30 min. * P Ͻ 0.05 compared with control; † P Ͻ 0.05 compared with H 2 O 2 . Fig. 2 . Temporal measurements of lung weight. Lung weight was determined by hanging the lungs from a balanced force transducer. Time 0 denotes commencement of infusion of H 2 O 2 at a rate of 80 nmol · ml Ϫ1 ·ml Ϫ1 for 15 min, 60 nmol · ml Ϫ1 ·ml Ϫ1 for 10 min, 40 nmol · ml Ϫ1 ·ml Ϫ1 for 15 min, and 20 nmol · ml Ϫ1 ·ml Ϫ1 for 10 min or vehicle control into pulmonary arterial line. In designated rats, 8 µM isoproterenol or 1 µM CP-80633 was injected (arrow) into perfusate reservoir 30 min after start of H 2 O 2 infusion. Posttreatment with isoproterenol increased rate of lung weight gain due presumably to a combination of an isoproterenol-induced vasodilation and a H 2 O 2 -induced increase in fluid filtration. Posttreatment with CP-80633 prevented H 2 O 2 -induced increase in lung weight due, in part, to significant decrease in pulmonary capillary pressure (see Table 2 ). Values are means Ϯ SE; n, no. of rats in each group. * P Ͻ 0.05 compared with control value. 0.05 to 0.65 Ϯ 0.10 ( Fig. 3 and Table 3 ) and increased PS from the H 2 O 2 value of 32 Ϯ 47 to 82 Ϯ 38 µl · min Ϫ1 · g dry lung Ϫ1 (Fig. 3 and Table 3 ). A similar value for PS (91 µl · min Ϫ1 · g dry lung Ϫ1 ) was determined when PS was directly measured at J v ϭ 0 in one rat infused with H 2 O 2 and posttreated with isoproterenol. These results demonstrate that posttreatment with isoproterenol was partially effective in reducing the H 2 O 2 -induced decrease in but was ineffective in stabilizing lung weight.
Posttreatment with CP-80633. To determine the effects of inhibition of cAMP metabolism on the H 2 O 2 -induced increases in hemodynamics, weight, and albumin clearance of the lung, 1 µM CP-80633 was injected as a bolus into the recirculating reservoir 30 min into the infusion of H 2 O 2 . CP-80633 also reduced the H 2 O 2 -induced increases in pulmonary arterial pressure and pulmonary arterial resistance, as did isoproterenol, but, in addition, CP-80633 also reduced pulmonary capillary pressure and pulmonary venous resistance within 10 min (Table 2 ). This significant decrease in postcapillary hemodynamics was associated with a complete block of the H 2 O 2 -induced increase in lung weight (Fig. 2) . CP-80633 significantly reduced the H 2 O 2 -induced decrease in from 0.38 Ϯ 0.05 to 0.79 Ϯ 0.06 (Fig. 3 and Table 3 ). H 2 O 2 in the presence of CP-80633 increased PS from the H 2 O 2 value of 32 Ϯ 47 to 67 Ϯ 36 µl · min Ϫ1 · g dry lung Ϫ1 . Similar values for PS (34 Ϯ 5 to 54 Ϯ 6 µl · min Ϫ1 · g dry lung Ϫ1 ) were obtained when PS was directly measured at J v ϭ 0 in two control rats and in two rats infused with H 2 O 2 and posttreated with CP-80633 (Fig. 3 ). These results demonstrate that posttreatment with CP-80633 was effective in attenuating the H 2 O 2 -induced increases in convective clearance of albumin and lung weight. Furthermore, an increase in PS was evident when H 2 O 2 was delivered in the presence of isoproterenol or CP-80633.
DISCUSSION
The first objective of the present study was to determine which parameters of increased transvascular protein permeability were altered by an infusion of H 2 O 2 into the isolated, perfused rat lung. The and PS were calculated from nonlinear regression analysis of 125 I-albumin clearance (J s /C p ) as a function of J v . An infusion of H 2 O 2 into the pulmonary artery increased lung weight and decreased . There was no change in PS, which was masked by the vasoconstriction induced by H 2 O 2 . The second objective was to compare the efficacy of posttreatment with cAMP-enhancing agents that function either by inhibition of the type 4 phosphodiesterase or by activation of the ␤ 2 -adrenergic receptor. Stimulation of cAMP production by posttreatment with isoproterenol attenuated the decrease in and augmented the increase in lung weight induced by H 2 O 2 . Inhibition of cAMP metabolism by CP-80633, a phosphodiesterase 4 inhibitor, more effectively attenuated the decrease in compared with isoproterenol and prevented the increase in lung weight. The vasodilation induced by these cAMP-enhancing agents unmasked the increased PS induced by H 2 O 2 . Therefore, H 2 O 2 increased the convective and diffusive clearances of albumin in an intact pulmonary vasculature.
While developing a model of a H 2 O 2 -induced increase in transvascular clearance of albumin in the isolated, perfused rat lung, we determined that the artificial perfusate contained 73 µM iron. Because the availability of only one coordination site in ferrous iron (Fe 2ϩ ) is needed for the reduction of H 2 O 2 to ⅐ OH (8, 16) , it would be essential to minimize the content of free iron in the perfusate to maximize the delivery of H 2 O 2 to the pulmonary vascular endothelium. To this end, DFO or HES-DFO was added to the perfusate at a dose of 150 µM to obtain a 2:1 ratio of iron chelator to perfusate iron; each DFO molecule can wrap around an iron molecule and successfully chelate all four coordination sites (8, 16) . Both forms of DFO were successful in Values are means Ϯ SE; nos. in parentheses, no. of rats in each group. cAMP-enhancing agents were given as a 30-min posttreatment. and PS were determined by nonlinear regression of 125 Ilabeled albumin clearance vs. fluid filtration (see Fig. 3 ). * P Ͻ 0.05 compared with control value; † P Ͻ 0.05 compared with H 2 O 2 value. delaying the onset of fulminant alveolar edema induced by an infusion of 40 nmol · ml Ϫ1 · min Ϫ1 of H 2 O 2 into the pulmonary arterial line. Another iron chelator, U-74500A, has also been shown to be effective in attenuating the increased capillary permeability induced by ischemia-reperfusion or tert-butyl hydroperoxide (9) . There are reports in the literature that lowmolecular-weight DFO is permeable to endothelial cells and can chelate intracellular free iron and protect cells against oxidant injury (16) . To prevent the blockade of this potentially important cellular pathway of oxidant injury, high-molecular-weight HES-DFO, which is not permeable to cells, was used, allowing H 2 O 2 to freely enter the cell and interact with any available free iron. The concentration of H 2 O 2 infused into the pulmonary arterial line and that sampled in the perfusate 80 cm downstream at the entrance to the lung were identical as measured by the xylenol orange assay; no H 2 O 2 was detected in the perfusate exiting the lungs (data not shown). Thus the addition of HES-DFO to the perfusate minimized the extracellular conversion of H 2 O 2 to ⅐ OH. Because the concentration of H 2 O 2 did not change in the perfusate entering the lungs and no H 2 O 2 was detected in the eluate, we conclude that H 2 O 2 diffused into the lungs. However, it is possible that some of the H 2 O 2 could have been converted by myeloperoxidase, released by any remaining polymorphonuclear leukocytes, into hypochlorous acid, although this conversion would have had to occur in close proximity to the endothelial cells as albumin in the perfusate could scavenge the hypochlorous acid. The fact that we saw an identical delay in lung weight gain induced by H 2 O 2 in both groups treated with DFO and HES-DFO would suggest that DFO is not permeable and, therefore, like HES-DFO only binds extracellular free iron. Alternatively, any amount of DFO in the perfusate not chelated to iron that may permeate the endothelial cells and bind intracellular free iron may have an insignificant effect on the generation of intracellular ⅐ OH, because the conversion of H 2 O 2 to ⅐ OH requires very little free iron (8) . These findings emphasize the importance of ensuring that H 2 O 2 , and not an iron-dependent metabolite, is delivered to cells when the effects of H 2 O 2 are studied in a perfusate requiring albumin.
In vitro studies using endothelial cell monolayers have demonstrated that H 2 O 2 increases K f and diffusive and convective clearances of protein (27, 28) and that cAMP-enhancing agents prevent and reverse the increase in K f and protein clearance (21, 28) . In situ studies using the isolated, perfused lung have shown that H 2 O 2 , administered as a bolus or by infusion into the recirculating reservoir, increases pulmonary arterial pressure, K f , lung weight, and transvascular protein clearance. In addition, pretreatment with cAMPenhancing agents attenuates the increases in pulmonary arterial pressure, K f , and lung weight (7, 26) . We also chose the isolated, perfused lung model to assess whether H 2 O 2 and cAMP-enhancing agents alter transvascular protein clearance, an initial cause of acute respiratory distress syndrome. This model represents the intact vascular endothelium of a whole lung, an improvement on studies that use endothelial cell monolayers. Furthermore, the measurement of transvascular protein clearance can be obtained in this model (15, 30, 34) , and two parameters, PS and , that define the restrictive properties of the vascular endothelium to the diffusive and convective clearances of protein, respectively, can be calculated. The latter parameter, , is independent of vascular surface area, unlike the parameters PS, K f , and lung weight, which can be affected by changes in vascular surface area induced by the vasoactive properties of H 2 O 2 and cAMP-enhancing agents.
One of the significant findings of the present study was that was decreased by an infusion of H 2 O 2 from a control value of 0.93 to 0.38. This result demonstrates that H 2 O 2 increases the convective clearance of albumin across an intact vascular endothelium. Although was markedly decreased by H 2 O 2 , diffusive clearance (PS), calculated as the y-intercept by using nonlinear regression analysis of J s /C p at different J v , was not affected by an infusion of H 2 O 2 ( Table 3 ). H 2 O 2 constricted the vasculature upstream from the capillary bed. Thus an increase in diffusive permeability with a coinciding decrease in vascular surface area due to precapillary constriction could cancel each other and result in no change in PS. In contrast, PS increased when H 2 O 2 was posttreated with either cAMP-enhancing agent, most likely due to the vasodilatory effects of intracellular cAMP that unmasked the precapillary constriction. This increase in PS induced by H 2 O 2 in the presence of isoproterenol and CP-80633, however, is most likely underestimated for two reasons. First, these cAMP-enhancing agents would be expected to decrease the diffusive permeability of albumin as indicated by the elevation in and as demonstrated in the literature using endothelial cell monolayers (18, 19) . Second, the increase in J s , which is accentuated under nonisogravimetric conditions, would increase the C i during the 3-min infusion of the tracer. This would result in a diminished concentration gradient from the vascular space to the interstitium during the infusion period compared with that in the control group under isogravimetric conditions. This increase in C i would also create a greater concentration gradient from the interstitium to the vascular space during the 3-min washout period, causing a greater back flux of tracer from the interstitium. These findings demonstrate that H 2 O 2 increases the convective clearance of albumin across the vascular endothelium and that diffusive clearance induced by H 2 O 2 can be masked by a concomitant increase in precapillary constriction. A previous publication in which an arachidonic acid-induced increase in albumin clearance was significantly attentuated with isoproterenol supports the above findings and interpretations (15) . We demonstrated that arachidonic acid, like H 2 O 2 , significantly decreased . Arachidonic acid was infused in combination with indomethacin to minimize changes in capillary pressure and vascular resistances, and, as a result, PS increased. Isoproterenol attenuated the decrease in and the increase in PS induced by arachidonic acid. Capillary pressure and resistances were also unchanged when arachidonic acid was infused in the presence of isoproterenol, demonstrating that isoproterenol can modify the parameters of albumin clearance, and PS, independently of changes in hemodynamics.
H 2 O 2 also increased lung weight as a result of increases in capillary pressure and the transvascular clearance of albumin. Posttreatment with isoproterenol augmented the H 2 O 2 -induced increase in lung weight, whereas a posttreatment with CP-80633 prevented the increase in lung weight. Although both agents reduced the H 2 O 2 -induced increases in pulmonary arterial pressure and pulmonary arterial resistance, CP-80633 also reduced pulmonary capillary pressure and pulmonary venous resistance and, hence, decreased hydrostatic pressure in the lung, which would result in a decrease in lung weight. Therefore, CP-80633 prevented the H 2 O 2 -induced increase in lung weight via a hemodynamic mechanism, as well as by reducing the H 2 O 2 -induced increase in transvascular clearance of albumin.
We, as well as others, have demonstrated the permeability-decreasing activity of various cAMP-enhancing agents using a variety of inflammatory agents, diseases, and syndromes (1, 7, 15, 18-21, 26, 28, 29) . For example, both rolipram, a phosphodiesterase 4 inhibitor like CP-80633, and isoproterenol reversed the increased pulmonary capillary permeability induced by ischemia-reperfusion in the isolated, perfused rat lung (1) . However, in the present study, the significant finding was that CP-80633 reduced the H 2 O 2 -induced decrease in more effectively than did isoproterenol. This finding suggests that the use of ␤ 2 -adrenergic receptor agonists, which stimulate the production of intracellular cAMP, may not be as effective in counteracting the increase in transvascular protein clearance induced by reactive oxygen species such as H 2 O 2 and ⅐ OH (5). These oxidants have been reported to influence the components involved in the production of cAMP. These proposed effects are 1) a decrease in the affinity of the ␤ 2 -adrenergic receptor by ⅐ OH (17); 2) a decrease in intracellular ATP (10); 3) a decrease in the activity of adenylate cyclase (17) ; and/or 4) an increase in the metabolism of cAMP (14) . Another possibility is that H 2 O 2 may directly alter the structure and activity of isoproterenol. Because production of cAMP may be attenuated by reactive oxygen species, we also treated lungs with the phosphodiesterase 4 inhibitor, CP-80633, as a means of decreasing catabolism of cAMP and increasing intracellular levels of cAMP. CP-80633, compared with isoproterenol, attenuated the H 2 O 2 -induced decrease in more effectively. In addition, CP-80633 decreased capillary pressure. These findings suggest that CP-80633 decreases the catabolism of intracellular cAMP in both vascular smooth muscle and endothelial cells and that CP-80633 would be more effective at decreasing the development of pulmonary edema because it affects both the barrier properties and hemodynamics of the vasculature that lead to increased transvascular protein and fluid fluxes.
In conclusion, the results of the present study demonstrate that an inhibitor of cAMP metabolism was more effective, compared with a stimulator of cAMP production, in reducing the transvascular clearance of albumin and lung weight induced by H 2 O 2 . Furthermore, the addition of DFO to the perfusate of the isolated lung minimized the conversion of H 2 O 2 to an iron-dependent metabolite, thus maximizing the delivery of H 2 O 2 to the vascular endothelium.
